# IO Biotech will file for bankruptcy after failure of cancer vaccine in key trial - Date: 2026-04-01 - Category: Biotech & Life Sciences The failed melanoma vaccine showed a 16.6-month benefit in one subgroup but missed its primary endpoint. Now a bankruptcy trustee is selling the IP — and the price will tell us if the field sees salvage value in a statistical miss. ---